The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Export 11032 results:
[ Author(Desc)] Title Type Year
Filters: Filter is   [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zarogoulidis, P., Trakada G., & Zarogoulidis K. (2013).  A chrono-target chemotherapy treatment model for lung cancer treatment.. Ther Deliv. 4(1), 5-8.
Zarogoulidis, P., Papadopoulos V., Maragouli E., Papatsibas G., Sardeli C., Man Y-G., et al. (2018).  Nivolumab as first-line treatment in non-small cell lung cancer patients-key factors: tumor mutation burden and PD-L1 ≥50.. Transl Lung Cancer Res. 7(Suppl 1), S28-S30.
Zarogoulidis, P., Petridis D., Ritzoulis C., Li Q., Huang H., Ning Y., et al. (2013).  Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.. Int J Pharm. 458(1), 39-47.
Zarogoulidis, P., Kioumis I., Ritzoulis C., Petridis D., Darwiche K., Porpodis K., et al. (2013).  New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam.. Int J Pharm. 455(1-2), 182-8.
Zarogoulidis, P., Kouliatsis G., Papanas N., Spyratos D., Constantinidis T. C., Kouroumichakis I., et al. (2011).  Long-term respiratory follow-up of H1N1 infection.. Virol J. 8, 319.
Zarogoulidis, P., Porpodis K., Kioumis I., Petridis D., Lampaki S., Spyratos D., et al. (2014).  Experimentation with inhaled bronchodilators and corticosteroids.. Int J Pharm. 461(1-2), 411-8.
Zarogoulidis, P., Katsikogianni F., Tsiouda T., Sakkas A., Katsikogiannis N., & Zarogoulidis K. (2014).  Interleukin-8 and interleukin-17 for cancer.. Cancer Invest. 32(5), 197-205.
Zarogoulidis, P., Darwiche K., Krauss L., Huang H., Zachariadis G. A., Katsavou A., et al. (2013).  Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients.. Future Oncol. 9(9), 1307-13.
Zarogoulidis, K., Zarogoulidis P., Darwiche K., Tsakiridis K., Machairiotis N., Kougioumtzi I., et al. (2013).  Malignant pleural effusion and algorithm management.. J Thorac Dis. 5 Suppl 4, S413-9.
Zarogoulidis, P., Christakidis V., Petridis D., Sapalidis K., Kosmidis C., Vagionas A., et al. (2020).  Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination.. Expert Rev Respir Med.
Zarogoulidis, P., Kioumis I., Papanas N., Manika K., Kontakiotis T., Papagianis A., et al. (2012).  The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literature.. J Chemother. 24(3), 173-7.
Zarogoulidis, P., Kioumis I., Porpodis K., Spyratos D., Tsakiridis K., Huang H., et al. (2013).  Clinical experimentation with aerosol antibiotics: current and future methods of administration.. Drug Des Devel Ther. 7, 1115-34.
Zarogoulidis, P., Orfanidis M., Constadinidis T. C., Eleutheriadou E., Kontakiotis T., Kerenidi T., et al. (2011).  A 26-year-old male with mesothelioma due to asbestos exposure.. Case Rep Med. 2011, 951732.
Zarogoulidis, P., Pavlioglou P., Le Pivert P., Machairiotis N., Katsikogiannis N., Kougioumtzi I., et al. (2014).  Current and future intratumoral targeted treatment for pancreatic cancer.. Ther Deliv. 5(8), 913-26.
Zarogoulidis, P., Sardeli C., Konstantinou F., & Sapalidis K. (2018).  Conventional Versus Therapeutic Stents for Airway Malignancies: Novel Local Therapies Underway.. EBioMedicine. 33, 10-11.
Zarogoulidis, K., Boutsikou E., Zarogoulidis P., Eleftheriadou E., Kontakiotis T., Lithoxopoulou H., et al. (2009).  The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis.. Int J Cancer. 125(7), 1705-9.
Zarogoulidis, P., Draba V., Machairiotis N., Manika K., Mikroulis D., Tsakiridis K., et al. (2012).  Fibrinous tumor of the pleura: an orphan disease lost in translation.. J Thorac Dis. 4(5), 497-503.
Zarogoulidis, P., Sapalidis K., Fyntanidou V., Kosmidis C., Amaniti A., Koulouris C., et al. (2019).  Evaluating the use of elastography in endobronchial ultrasound technique as a diagnostic approach for mesothorax lymphadenopathy.. Expert Rev Respir Med. 13(12), 1153-1159.
Zarogoulidis, K., Eleftheriadou E., Kontakiotis T., Gerasimou G., Zarogoulidis P., Sapardanis I., et al. (2012).  Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients.. Lung Cancer. 76(1), 84-8.
Zarogoulidis, P., Darwiche K., Tsakiridis K., Teschler H., Yarmus L., Zarogoulidis K., et al. (2013).  Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis.. J Mol Genet Med. 7, 65.
Zarogoulidis, P., Kosmidis C., Fyntanidou V., Aidoni Z., Tsakiridis K., Koulouris C., et al. (2019).  Biopsy and rebiopsy for non-small-cell lung cancer: current and future methods.. Lung Cancer Manag. 8(3), LMT16.
Zarogoulidis, P., Papadopoulos V., Maragouli E., Papatsibas G., & Huang H. (2017).  Checkpoint inhibitors in metastatic epidermal growth factor receptor-mutated non-small cell lung cancer patients: where we treating the wrong cancer?. J Thorac Dis. 9(9), 2771-2773.
Zarogoulidis, P., Porpodis K., Konoglou M., Saroglou M., Mitrakas A., Matthaios D., et al. (2011).  Serratia pneumonia presenting as hemoptysis in a patient with sarcoidosis: a case report.. Int J Gen Med. 4, 661-4.
Zarogoulidou, V., Panagopoulou E., Papakosta D., Petridis D., Porpodis K., Zarogoulidis K., et al. (2015).  Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary Department.. J Thorac Dis. 7(Suppl 1), S12-9.
Zarpalas, D., Gkontra P., Daras P., & Maglaveras N. (2014).  Gradient-based reliability maps for ACM-based segmentation of hippocampus.. IEEE Trans Biomed Eng. 61(4), 1015-26.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.